Itron’s (ITRI) “Hold” Rating Reiterated at Argus

Argus reissued their hold rating on shares of Itron (NASDAQ:ITRI) in a research note issued to investors on Tuesday, MarketBeat Ratings reports.

A number of other equities research analysts have also issued reports on ITRI. Zacks Research upgraded Itron from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 14th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Itron in a research note on Wednesday, October 8th. Stephens raised Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 target price on the stock in a research note on Monday. Wall Street Zen raised Itron from a “hold” rating to a “buy” rating in a report on Saturday, November 1st. Finally, Robert W. Baird reaffirmed a “neutral” rating and set a $118.00 price objective (down from $137.00) on shares of Itron in a report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Itron presently has a consensus rating of “Moderate Buy” and a consensus price target of $139.00.

Itron Stock Down 1.1%

NASDAQ ITRI opened at $105.99 on Tuesday. The stock’s 50-day moving average price is $123.29 and its 200-day moving average price is $123.06. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. Itron has a 52 week low of $90.11 and a 52 week high of $142.00. The company has a market capitalization of $4.85 billion, a P/E ratio of 18.12, a price-to-earnings-growth ratio of 0.76 and a beta of 1.52.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.06. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company had revenue of $581.63 million during the quarter, compared to the consensus estimate of $578.49 million. During the same period in the previous year, the company posted $1.84 EPS. The firm’s revenue was down 5.5% on a year-over-year basis. Itron has set its FY 2025 guidance at 6.840-6.940 EPS. Q4 2025 guidance at 2.150-2.250 EPS. On average, equities research analysts predict that Itron will post 5.33 earnings per share for the current year.

Insider Transactions at Itron

In related news, SVP John F. Marcolini sold 565 shares of Itron stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $70,800.15. Following the completion of the transaction, the senior vice president owned 14,396 shares in the company, valued at approximately $1,803,962.76. This trade represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Justin K. Patrick sold 388 shares of the firm’s stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $48,620.28. Following the completion of the sale, the senior vice president directly owned 20,761 shares of the company’s stock, valued at $2,601,560.91. The trade was a 1.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 3,037 shares of company stock worth $380,566. 1.45% of the stock is currently owned by corporate insiders.

Institutional Trading of Itron

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of Itron in the second quarter valued at $30,000. Bessemer Group Inc. grew its holdings in Itron by 125.7% during the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after purchasing an additional 142 shares during the last quarter. Salomon & Ludwin LLC bought a new position in Itron during the 3rd quarter valued at about $42,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of Itron by 343.6% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock valued at $46,000 after buying an additional 268 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in shares of Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after buying an additional 81 shares during the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.